Related references
Note: Only part of the references are listed.NCX-1000, a Nitric Oxide-Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study
Annalisa Berzigotti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability
Kuei-Chuan Lee et al.
CLINICAL SCIENCE (2010)
Increased Plasma Malondialdehyde in Patients with Viral Cirrhosis and Its Relationships to Plasma Nitric Oxide, Endotoxin, and Portal Pressure
Kuei-Chuan Lee et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study
Aezam Katoonizadeh et al.
GUT (2010)
Treatment with the Leukotriene Inhibitor Montelukast for 10 Days Attenuates Portal Hypertension in Rat Liver Cirrhosis
Christian J. Steib et al.
HEPATOLOGY (2010)
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites
Thomas Serste et al.
HEPATOLOGY (2010)
Angiotensin II and NADPH Oxidase Increase ADMA in Vascular Smooth Muscle Cells
Zaiming Luo et al.
HYPERTENSION (2010)
Simvastatin effects on portal-systemic collaterals of portal hypertensive rats
Hui-Chun Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension
Jaume Bosch et al.
JOURNAL OF HEPATOLOGY (2010)
Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis
Puneeta Tandon et al.
JOURNAL OF HEPATOLOGY (2010)
Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?
Dominique Thabut et al.
JOURNAL OF HEPATOLOGY (2010)
Haemodynamic and renal effects of tadalafil in patients with cirrhosis
Georgios N. Kalambokis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
J. Vlachogiannakos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats
William Kemp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
Montserrat Moreno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver
Leonie Halverscheid et al.
BMC GASTROENTEROLOGY (2009)
Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model
Milan C. Richir et al.
CRITICAL CARE MEDICINE (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension
B. Lavina et al.
GUT (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Pharmacological Inhibition of Integrin αvβ3 Aggravates Experimental Liver Fibrosis and Suppresses Hepatic Angiogenesis
Eleonora Patsenker et al.
HEPATOLOGY (2009)
Randomized Controlled Trial of Carvedilol Versus Variceal Band Ligation for the Prevention of the First Variceal Bleed
Dhiraj Tripathi et al.
HEPATOLOGY (2009)
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension
Vincenzo La Mura et al.
JOURNAL OF HEPATOLOGY (2009)
Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine
Jiang Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis
Vanessa P. Stadlbauer et al.
GASTROENTEROLOGY (2008)
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
Kojiro Taura et al.
GASTROENTEROLOGY (2008)
Platelet-derived growth factor signaling through ephrin-B2 regulates hepatic vascular structure and function
David Semela et al.
GASTROENTEROLOGY (2008)
Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats
Vasilica Matei et al.
JOURNAL OF HEPATOLOGY (2008)
The management of portal hypertension: Rational basis, available treatments and future options
Jaime Bosch et al.
JOURNAL OF HEPATOLOGY (2008)
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
Puneeta Tandon et al.
SEMINARS IN LIVER DISEASE (2008)
Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats
Jonel Trebicka et al.
HEPATOLOGY (2008)
Increased oxidative stress in cirrhotic rat livers:: A potential mechanism contributing to reduced nitric oxide bioavailability
Jorge Gracia-Sancho et al.
HEPATOLOGY (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats
Dominique Thabut et al.
HEPATOLOGY (2007)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
Jonel Trebicka et al.
HEPATOLOGY (2007)
Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis
Rajeshwar P. Mookerjee et al.
GASTROENTEROLOGY (2007)
Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis
D. Rincon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure
Rajeshwar P. Mookerjee et al.
LIVER TRANSPLANTATION (2007)
Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis
Rajeshwar P. Mookerjee et al.
HEPATOLOGY (2007)
Hepatic guanylate cyclase activity is decreased in a model of cirrhosis: A quantitative cytochemistry study
NA Davies et al.
FEBS LETTERS (2006)
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
A Blasco et al.
HEPATOLOGY (2006)
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis
W Laleman et al.
HEPATOLOGY (2005)
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis
C Zafra et al.
GASTROENTEROLOGY (2004)
The hepatic venous pressure gradient: Anything worth doing should be done right
RJ Groszmann et al.
HEPATOLOGY (2004)
Angiogenesis in chronic inflammatory liver disease
J Medina et al.
HEPATOLOGY (2004)
Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity
SK Baik et al.
JOURNAL OF GASTROENTEROLOGY (2003)
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver
S Fiorucci et al.
JOURNAL OF HEPATOLOGY (2003)
The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis - A randomized trial
B Rasaratnam et al.
ANNALS OF INTERNAL MEDICINE (2003)
Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis
RP Mookerjee et al.
GUT (2003)
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis
JG Abraldes et al.
HEPATOLOGY (2003)
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis
W Ruiz-del-Arbol et al.
HEPATOLOGY (2003)
Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers
AA Dudenhoefer et al.
HEPATOLOGY (2002)
Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension
A Escorsell et al.
HEPATOLOGY (2000)
Share Paper
